PURPOSE: To evaluate the use of global indices summarizing the current status of a patient's visual field as predictors of their future rate of change. METHODS: Ninety-five subjects with early or suspected glaucoma were studied, of whom 50 exhibited glaucomatous optic neuropathy (GON) at baseline. Subjects underwent seven annual visual field tests. Results from the first test in the sequence were used to predict their subsequent rate of change. Two global indices were considered: mean deviation (MD) and pattern standard deviation (PSD). RESULTS: Using multiple linear regression, baseline MD predicted subsequent slope of MD significantly better than baseline PSD predicted subsequent slope of PSD (p = 0.017). Using multiple logistic regression, a worse initial MD was predictive of being in the worst tertile for subsequent change in MD (pseudo-R2 = 0.33 for subjects with GON at baseline and 0.31 for those without). Worse initial PSD was not predictive of being in the worst tertile for subsequent change in PSD (pseudo-R2 = 0.09 with GON at baseline, 0.10 without). CONCLUSIONS: Among patients with otherwise similar clinical profiles, a worse visual field at baseline, as measured by the global index MD, is predictive of a more rapid future rate of change. This should be taken into account when clinical decisions are made concerning management of patients who already have some visual field damage at presentation.
PURPOSE: To evaluate the use of global indices summarizing the current status of a patient's visual field as predictors of their future rate of change. METHODS: Ninety-five subjects with early or suspected glaucoma were studied, of whom 50 exhibited glaucomatous optic neuropathy (GON) at baseline. Subjects underwent seven annual visual field tests. Results from the first test in the sequence were used to predict their subsequent rate of change. Two global indices were considered: mean deviation (MD) and pattern standard deviation (PSD). RESULTS: Using multiple linear regression, baseline MD predicted subsequent slope of MD significantly better than baseline PSD predicted subsequent slope of PSD (p = 0.017). Using multiple logistic regression, a worse initial MD was predictive of being in the worst tertile for subsequent change in MD (pseudo-R2 = 0.33 for subjects with GON at baseline and 0.31 for those without). Worse initial PSD was not predictive of being in the worst tertile for subsequent change in PSD (pseudo-R2 = 0.09 with GON at baseline, 0.10 without). CONCLUSIONS: Among patients with otherwise similar clinical profiles, a worse visual field at baseline, as measured by the global index MD, is predictive of a more rapid future rate of change. This should be taken into account when clinical decisions are made concerning management of patients who already have some visual field damage at presentation.
Authors: David S Friedman; M Roy Wilson; Jeffrey M Liebmann; Robert D Fechtner; Robert N Weinreb Journal: Am J Ophthalmol Date: 2004-09 Impact factor: 5.258
Authors: Nicholas G Strouthidis; Andrew Scott; Ananth C Viswanathan; David P Crabb; David F Garway-Heath Journal: Invest Ophthalmol Vis Sci Date: 2007-01 Impact factor: 4.799
Authors: Paul H Artes; Marcelo T Nicolela; Raymond P LeBlanc; Balwantray C Chauhan Journal: Invest Ophthalmol Vis Sci Date: 2005-12 Impact factor: 4.799
Authors: Kouros Nouri-Mahdavi; Douglas Hoffman; Anne L Coleman; Gang Liu; Gang Li; Douglas Gaasterland; Joseph Caprioli Journal: Ophthalmology Date: 2004-09 Impact factor: 12.079
Authors: Stuart K Gardiner; Shaban Demirel; Carlos Gustavo De Moraes; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass Journal: Invest Ophthalmol Vis Sci Date: 2013-02-15 Impact factor: 4.799
Authors: Steven L Mansberger; Shivali A Menda; Brad A Fortune; Stuart K Gardiner; Shaban Demirel Journal: Am J Ophthalmol Date: 2016-11-04 Impact factor: 5.258
Authors: Richard A Russell; Rizwan Malik; Balwantray C Chauhan; David P Crabb; David F Garway-Heath Journal: Invest Ophthalmol Vis Sci Date: 2012-05-14 Impact factor: 4.799
Authors: Mitra Sehi; Xinbo Zhang; David S Greenfield; Yunsuk Chung; Gadi Wollstein; Brian A Francis; Joel S Schuman; Rohit Varma; David Huang Journal: Am J Ophthalmol Date: 2012-10-01 Impact factor: 5.258